Predictive Oncology Inc.
POAI
$6.00
$0.458.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -503.68% | 10.09% | 6.28% | -17.04% | 8.46% |
| Total Depreciation and Amortization | 10.23% | 29.37% | 23.83% | 11.08% | 31.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8,146.10% | -71.19% | 179.78% | 43.19% | -76.78% |
| Change in Net Operating Assets | 182.39% | -265.26% | -292.43% | -49.84% | -317.71% |
| Cash from Operations | 38.85% | 26.67% | 29.46% | 9.35% | 3.39% |
| Capital Expenditure | -100.00% | -100.00% | 100.00% | 98.86% | 103.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,512.72% | 4,569.39% | 5,566.39% | 174.56% | 154.75% |
| Cash from Investing | 1,997.32% | 10,870.49% | 351.45% | 107.44% | 107.98% |
| Total Debt Issued | -4.03% | -4.03% | -- | -- | -- |
| Total Debt Repaid | 19.73% | -5.73% | -40.91% | -287.52% | -- |
| Issuance of Common Stock | -7.08% | 19.87% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 93.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 72.34% | 12.88% | -- | -- | -- |
| Cash from Financing | 8.36% | 15.42% | 17,848.77% | 2,545.53% | 1,600.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.21% | 48.84% | 84.37% | 40.09% | 34.44% |